Have you ever used Alexa to help you decide what movie you should watch? Maybe you asked Siri for restaurant recommendations. Artificial intelligence and virtual assistants are constantly being refined, and may soon be making appointments for you, offering medical advice, or trying to sell you a bottle of wine.
Although AI technology has miles to go to develop social skills on par with ours, some AI has shown impressive language understanding and can complete relatively complex interactive tasks.
A new analysis of how the immune system responds to both older and newer investigational vaccines for respiratory syncytial virus—RSV—will help inform the ultimate translation of an immunization from the laboratory to actual clinical usage.
The research couldn’t arrive at a more crucial time. The unexpected, and dramatic, worldwide escalation of RSV cases in recent months helped demonstrate why a vaccine to prevent the infectious illness is so critically needed. Each year, RSV is responsible for 1 in 50 pediatric deaths worldwide, according to researchers at Wilhelmina Children’s Hospital in the Netherlands, where medical researchers recently completed a study on RSV.
The majority of those deaths occur among infants too young to fight the viral disease. But the infectious agent also is a killer of frail, older adults, data from the World Health Organization show, making the development of an effective vaccine a medical priority to prevent unnecessary deaths at opposite ends of the human age spectrum.
Kevin Systrom and Mike Krieger, the co-founders of Instagram, have launched a brand new app called Artifact. This revolutionary software uses artificial intelligence (AI) technology to provide users with a personalized news feed. Currently, an invitation code is required to access the app; however, individuals can join a waitlist in order to gain early access. Systrom and Krieger left Instagram back in 2018 after working for eight years at the Facebook-owned company. Although they publicly stated that their departure was due to their desire to explore creativity and curiosity again, tensions between the two co-founders and CEO Mark Zuckerberg were also reported. Last year, the duo debuted a website dedicated to tracking the spread of COVID-19.
The godfather of vaccines discussing the future of vaccinology — dr. stanley plotkin, MD.
Dr. Stanley Plotkin, MD (https://en.wikipedia.org/wiki/Stanley_Plotkin), is an American physician, scientist, and scholar, who in the 1960s, while working at Wistar Institute in Philadelphia, played a pivotal role in discovery of a vaccine against rubella virus (which is now used worldwide as a key component of the MMR vaccine), and has worked extensively on the development and application of a wide range of other vaccines including those for polio, rabies, varicella, rotavirus and cytomegalovirus (https://www.epiv.eu/).
Dr. Plotkin graduated from New York University in 1952 and obtained a medical degree at Downstate Medical Center in Brooklyn. He was a resident in pediatrics at the Children’s Hospital of Philadelphia and at the Hospital for Sick Children in London.
In 1957, Dr. Plotkin served in the Epidemic Intelligence Service of the Centers for Disease Control (CDC) of the U.S. Public Health Service for three years and then served as a member of Wistar’s active research faculty from 1960 to 1991.
Today, in addition to his emeritus appointment at Wistar, Dr. Plotkin is emeritus professor of Pediatrics at the University of Pennsylvania (https://www.med.upenn.edu/apps/faculty/index.php/g275/p1554), and works as a consultant advising vaccine manufacturers, biotechnology firms, non-profits and governments.
In some cases, it is now possible to genetically engineer the immune system to banish cancers like T-cell leukaemia that were previously unresponsive to treatments.
The YouTuber has received nearly 70 million views for his video.
MrBeast, the popular YouTuber, has helped 1,000 people see again by offering them free surgery. A trained surgeon completed the procedure, and the joy of those who underwent surgery knew no bounds. The entire event video was uploaded on Sunday and has so far gathered nearly 70 million views.
To clarify, the YouTuber isn’t promising some radically new treatment that allows blind people to see. Instead, it is a simple 10-minute procedure used to treat cataracts and is well-tested with quantifiable benefits. Before we get into the details, here’s where it can be used.
“Having focused on genetic advancements in ancient DNA for my entire career and as the first to fully sequence the Dodo’s genome, I am thrilled to collaborate with Colossal and the people of Mauritius on the de-extinction and eventual re-wilding of the Dodo. I particularly look forward to furthering genetic rescue tools focused on birds and avian conservation,” Shapiro added.
The world has witnessed many bizarre things, but seeing a biological body devoid of life become functional with the help of technology is a totally new tale. OSCAR, a living being formed from human cells, was born. Cornelis Vlasman is the protagonist, a talented biologist who believes that the path less trodden is, by definition, the least interesting. He creates his own laboratory with a few like-minded people, where he experiments with organic materials on his own initiative, with his own resources, and with his own crew.
After many years of hard labor, Vlasman’s team is successful in creating new life from cells collected from his own body. Under his guidance, OSCAR, the world’s first living organism, is being built. OSCAR is a human-sized prototype built with interactive organ modules created from human cells.
In a modular system, independent modules, similar to building blocks, constitute a transformable and thus changeable arrangement.
Physicists have invented a new type of analog quantum computer that can tackle hard physics problems that the most powerful digital supercomputers cannot solve.
New research published in Nature Physics by collaborating scientists from Stanford University in the U.S. and University College Dublin (UCD) in Ireland has shown that a novel type of highly-specialized analog computer, whose circuits feature quantum components, can solve problems from the cutting edge of quantum physics that were previously beyond reach. When scaled up, such devices may be able to shed light on some of the most important unsolved problems in physics.
For example, scientists and engineers have long wanted to gain a better understanding of superconductivity, because existing superconducting materials —such as those used in MRI machines, high speed train and long-distance energy-efficient power networks—currently operate only at extremely low temperatures, limiting their wider use. The holy grail of materials science is to find materials that are superconducting at room temperature, which would revolutionize their use in a host of technologies.
At our StrictlyVC event a few nights ago, Altman was generous with his time, spending an hour with those gathered to talk about the latest at OpenAI (the hottest startup in the world at the moment), as well as answering questions about how his other investments fit into larger themes that he expects to play out — and in the not-distant future.
This is part one of that interview, focused on Altman’s investments, including in Helion Energy, a nuclear fusion company that Altman described at the event as “the other thing beside OpenAI that I spend a lot of time on.” We also talked Twitter, supersonic jets, making babies out of skin cells, and why he’s “not super interested” in crypto.
עברית (Hebrew)
